Herbas VPB

Print
EN | LT
LT - ORAL FORMULATIONS OF METHYLNALTREXONE
EN - ORAL FORMULATIONS OF METHYLNALTREXONE

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 9/20 (2006.01)
A61K 9/2009 (2013.01)
A61K 31/485 (2006.01)
A61K 9/2013 (2013.01)
C07D 489/08 (2006.01)
A61K 9/2054 (2013.01)
A61P 1/00 (2006.01)
A61K 9/2077 (2013.01)
A61P 1/08 (2006.01)
A61K 31/485 (2013.01)
A61P 1/10 (2006.01)
A61P 1/00 (2018.01)
A61P 1/14 (2006.01)
A61P 1/08 (2018.01)
A61P 25/04 (2006.01)
A61P 1/10 (2018.01)
A61P 1/14 (2018.01)
A61P 25/04 (2018.01)
C07D 489/08 (2013.01)
European patent
(11) Number of the document 3178472
(13) Kind of document T
(96) European patent application number 17153285.6
Date of filing the European patent application 2011-03-11
(97) Date of publication of the European application 2017-06-14
(45) Date of publication and mention of the grant of the patent 2021-10-27
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
313018 P 2010-03-11 US
Inventors
(72)
Shah, Syed M. , US
Diorio, Christopher Richard , US
Ehrnsperger, Eric C. , US
Meng, Xu , US
Shareffi, Kadum A. , US
Cohen, Jonathan Marc , US
Grantee
(73) Wyeth LLC , Five Giralda Farms, Madison, NJ 07940, US
Title
(54) ORAL FORMULATIONS OF METHYLNALTREXONE
  ORAL FORMULATIONS OF METHYLNALTREXONE